| Financial Year |
March 31 2023 |
| Monetary Funds |
7,114,496,844.71 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
151,644,000.00 |
| Accounts Receivable |
26,005,655.53 |
| Advances to Suppliers |
78,193,419.88 |
| Other Receivables |
38,765,328.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,038,635,844.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
508,802,560.78 |
| Total Current Assets |
12,956,543,653.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
904,755,348.49 |
| Fixed Assetes |
3,050,116,605.74 |
| Under-construction Projects |
127,864,339.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
20,523,304.72 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
676,887,996.66 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
29,862,524.03 |
| Deferred Income Tax Assets |
169,259,847.83 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
5,019,147,329.79 |
| Total Assets |
17,975,690,982.94 |
| Short-Term Loans |
2,695,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,329,404,203.35 |
| Accounts Received In Advance |
52,862,348.20 |
| Employee Compensation Payable |
80,184,759.45 |
| Taxes Payable |
141,792,277.84 |
| Interest Payable |
-- |
| Dividend Payable |
4,701,478.90 |
| Other payables |
90,804,118.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,702,093,875.38 |
| Other Current Liabilities |
187,773,913.90 |
| Sub-Total of Current Liabilities |
8,115,840,654.25 |
| Long-term Loans |
1,933,320,866.94 |
| Bonds Payable |
500,000,000.00 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,448,982,292.22 |
| Total Liabilities |
10,564,822,946.47 |
| Paid-In Capital(Or Share Stock) |
741,766,989.00 |
| Capital Surplus |
2,627,319,747.99 |
| Surplus Reserve |
881,590,384.60 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,185,026,748.18 |
| Minority Stockholder's Interest |
5,164,166.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,405,703,869.77 |
| Owner's Equity（Stockholder's Equity） |
7,410,868,036.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,975,690,982.94 |
